Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases.
about
Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002Pharmacogenomic genotyping methodologiesPost-mortem toxicology: what the dead can and cannot tell us.Pharmacogenetics of chronic pain and its treatment.Variable response to opioid treatment: any genetic predictors within sight?Sudden adult death.Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.Cytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications.CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.Codeine and opioid metabolism: implications and alternatives for pediatric pain management.Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management.Increasing the reach of forensic genetics with massively parallel sequencing.Human Cytochrome P450 Enzyme Modulation by Gymnema sylvestre: A Predictive Safety Evaluation by LC-MS/MSIs it farewell to codeine?Toxicogenetics--cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam.Tramadol: keep calm and carry on.Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.The CYP4502D6 *4 and *6 alleles are the molecular genetic markers for drug response: implications in colchicine non-responder FMF patients.Heterologous expression of human cytochromes P450 2D6 and CYP3A4 in Escherichia coli and their functional characterization.
P2860
Q23913035-8B245053-6121-463E-95CB-873D16086200Q29397112-EFD1EFBA-DFD2-4A8A-BAE2-9F0945B472E7Q35088652-6F1920FC-9191-485C-B78A-41ED6E62660AQ36900075-EFA71D74-1606-422B-95DF-DB21F2538770Q37187101-A0CBFB98-F48A-4895-AF1C-396A648BC2D9Q37556149-0921A9B2-FF5C-447A-917D-960C0595C1F0Q37876422-20806BE2-6793-4C97-99CE-B33CEBA32289Q38100710-9393B57C-FE08-4B2E-83AF-25CD81B34FEFQ38496627-0B8D68F6-AD9A-4A88-B1FA-3301ECCF57F9Q39190293-BA6C2AEA-E492-4052-AC77-EDF4DB36F94FQ39300905-2D1EDF15-98C1-4E46-946F-F511C377CD61Q39385024-D6329F36-D8A8-4D7C-A761-F7E716DFF262Q41487258-C8B35571-5CA6-4BEB-8D07-F35DB26A6017Q45033609-68FB7452-B630-4298-B2EA-1E15329E3E5EQ45968676-87354D09-3058-4845-AE11-8858C4EC4730Q47276375-C1BC1DB2-9F7A-4309-AC21-B73526B06FE0Q48490118-47A4E434-46DA-4747-A075-7D104541B683Q53621350-4A9B169B-E4CB-4AF3-B9E6-FAC31CD5237CQ55055040-EC82563F-144B-4103-8D34-78DBF921BD1F
P2860
Pharmacogenomics as molecular autopsy for postmortem forensic toxicology: genotyping cytochrome P450 2D6 for oxycodone cases.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@ast
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@en
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@nl
type
label
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@ast
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@en
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@nl
prefLabel
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@ast
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@en
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@nl
P2093
P356
P1476
Pharmacogenomics as molecular ...... P450 2D6 for oxycodone cases.
@en
P2093
B Charles Schur
Elvan Laleli-Sahin
Jeffrey M Jentzen
Paul J Jannetto
Steven H Wong
Susan B Gock
P304
P356
10.1093/JAT/26.7.438
P577
2002-10-01T00:00:00Z